442 related articles for article (PubMed ID: 15280526)
1. Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2.
Joo KW; Jeon US; Kim GH; Park J; Oh YK; Kim YS; Ahn C; Kim S; Kim SY; Lee JS; Han JS
Nephrol Dial Transplant; 2004 Oct; 19(10):2480-6. PubMed ID: 15280526
[TBL] [Abstract][Full Text] [Related]
2. Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans.
Bankir L; Fernandes S; Bardoux P; Bouby N; Bichet DG
J Am Soc Nephrol; 2005 Jul; 16(7):1920-8. PubMed ID: 15888562
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of aquaporin-2 in patients with diabetes insipidus.
Kanno K; Sasaki S; Hirata Y; Ishikawa S; Fushimi K; Nakanishi S; Bichet DG; Marumo F
N Engl J Med; 1995 Jun; 332(23):1540-5. PubMed ID: 7537863
[TBL] [Abstract][Full Text] [Related]
4. Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration.
Wilting I; Baumgarten R; Movig KL; van Laarhoven J; Apperloo AJ; Nolen WA; Heerdink ER; Knoers NV; Egberts AC
Eur J Pharmacol; 2007 Jul; 566(1-3):50-7. PubMed ID: 17466972
[TBL] [Abstract][Full Text] [Related]
5. Urinary aquaporin-2 excretion in dogs: a marker for collecting duct responsiveness to vasopressin.
van Vonderen IK; Wolfswinkel J; van den Ingh TS; Mol JA; Rijnberk A; Kooistra HS
Domest Anim Endocrinol; 2004 Aug; 27(2):141-53. PubMed ID: 15219933
[TBL] [Abstract][Full Text] [Related]
6. Dissociation between urine osmolality and urinary excretion of aquaporin-2 in healthy volunteers.
Baumgarten R; van de Pol MH; Deen PM; van Os CH; Wetzels JF
Nephrol Dial Transplant; 2000 Aug; 15(8):1155-61. PubMed ID: 10910438
[TBL] [Abstract][Full Text] [Related]
7. Cooperative mechanisms of acute antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus.
Moosavi SM; Haghani M
Can J Physiol Pharmacol; 2010 Dec; 88(12):1191-201. PubMed ID: 21164566
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
Radó JP; Marosi J; Fischer J; Takó J; Kiss N
Endokrinologie; 1975 Nov; 66(2):184-95. PubMed ID: 1236681
[TBL] [Abstract][Full Text] [Related]
9. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity.
Li Y; Shaw S; Kamsteeg EJ; Vandewalle A; Deen PM
J Am Soc Nephrol; 2006 Apr; 17(4):1063-72. PubMed ID: 16495377
[TBL] [Abstract][Full Text] [Related]
10. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
[TBL] [Abstract][Full Text] [Related]
11. Chronic dDAVP infusion in rats decreases the expression of P2Y2 receptor in inner medulla and P2Y2 receptor-mediated PGE2 release by IMCD.
Sun R; Miller RL; Hemmert AC; Zhang P; Shi H; Nelson RD; Kishore BK
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F768-76. PubMed ID: 15914777
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of urinary concentration in nephrogenic diabetes insipidus.
McConnell RF; Lorentz WB; Berger M; Smith EH; Carvajal HF; Travis LB
Pediatr Res; 1977 Jan; 11(1 Pt 1):33-6. PubMed ID: 188007
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of the antidiuretic effects of Adiuretin-SD (DDAVP) and Pitressin Tannate in diabetes insipidus.
Czakó L; Julesz J; László FA
Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):10-3. PubMed ID: 631964
[TBL] [Abstract][Full Text] [Related]
15. Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children.
Williams TD; Dunger DB; Lyon CC; Lewis RJ; Taylor F; Lightman SL
J Clin Endocrinol Metab; 1986 Jul; 63(1):129-32. PubMed ID: 3711257
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
Walker LA; Frölich JC
J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
[TBL] [Abstract][Full Text] [Related]
17. Role of aquaporin-2 gene expression in hyponatremic rats with chronic vasopressin-induced antidiuresis.
Saito T; Higashiyama M; Nagasaka S; Sasaki S; Saito T; Ishikawa SE
Kidney Int; 2001 Oct; 60(4):1266-76. PubMed ID: 11576341
[TBL] [Abstract][Full Text] [Related]
18. Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel.
Kim GH; Lee JW; Oh YK; Chang HR; Joo KW; Na KY; Earm JH; Knepper MA; Han JS
J Am Soc Nephrol; 2004 Nov; 15(11):2836-43. PubMed ID: 15504936
[TBL] [Abstract][Full Text] [Related]
19. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride.
Bedford JJ; Weggery S; Ellis G; McDonald FJ; Joyce PR; Leader JP; Walker RJ
Clin J Am Soc Nephrol; 2008 Sep; 3(5):1324-31. PubMed ID: 18596116
[TBL] [Abstract][Full Text] [Related]
20. An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus.
Kamsteeg EJ; Wormhoudt TA; Rijss JP; van Os CH; Deen PM
EMBO J; 1999 May; 18(9):2394-400. PubMed ID: 10228154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
